|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.98 USD | +1.16% |
|
+8.05% | -12.41% |
| 07-24 | BofA Adjusts Price Target on ResMed to $320 From $310 | MT |
| 07-21 | ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says | MT |
Company Valuation: ResMed, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 35,903 | 30,691 | 32,133 | 28,117 | 37,762 | 30,432 | - | - |
| Change | - | -14.52% | 4.7% | -12.5% | 34.31% | -19.41% | - | - |
| Enterprise Value (EV) 1 | 36,263 | 31,192 | 33,346 | 28,585 | 37,221 | 29,605 | 28,688 | 27,885 |
| Change | - | -13.98% | 6.9% | -14.28% | 30.21% | -20.46% | -3.1% | -2.8% |
| P/E | 76.1x | 39.6x | 35.9x | 27.7x | 27.1x | 19.9x | 18.6x | 16.1x |
| PBR | 12.4x | 9.35x | 7.76x | 5.78x | 6.33x | 4.64x | 4.21x | 3.81x |
| PEG | - | 0.6x | 2.4x | 2x | 0.7x | 1.7x | 2.62x | 1.1x |
| Capitalization / Revenue | 11.2x | 8.58x | 7.61x | 6x | 7.34x | 5.39x | 5.08x | 4.73x |
| EV / Revenue | 11.3x | 8.72x | 7.9x | 6.1x | 7.23x | 5.24x | 4.78x | 4.33x |
| EV / EBITDA | 33.8x | 26.8x | 25.3x | 18.1x | 19.8x | 13.4x | 12.3x | 11.1x |
| EV / EBIT | 40.1x | 31.2x | 27.2x | 19.3x | 21.1x | 14.5x | 13x | 11.7x |
| EV / FCF | 57.2x | 144x | 58.1x | 22x | 22.4x | 18.2x | 18.4x | 16.4x |
| FCF Yield | 1.75% | 0.69% | 1.72% | 4.55% | 4.46% | 5.5% | 5.44% | 6.1% |
| Dividend per Share 2 | 1.56 | 1.68 | 1.8 | 1.92 | 2.12 | 2.432 | 2.622 | 2.946 |
| Rate of return | 0.63% | 0.8% | 0.82% | 1% | 0.82% | 1.15% | 1.24% | 1.4% |
| EPS 2 | 3.24 | 5.3 | 6.09 | 6.92 | 9.51 | 10.59 | 11.35 | 13.08 |
| Distribution rate | 48.1% | 31.7% | 29.6% | 27.7% | 22.3% | 23% | 23.1% | 22.5% |
| Net sales 1 | 3,197 | 3,578 | 4,223 | 4,685 | 5,146 | 5,651 | 5,996 | 6,437 |
| EBITDA 1 | 1,074 | 1,162 | 1,317 | 1,576 | 1,884 | 2,201 | 2,338 | 2,515 |
| EBIT 1 | 903.7 | 1,000 | 1,224 | 1,478 | 1,763 | 2,039 | 2,207 | 2,374 |
| Net income 1 | 474.5 | 779.4 | 897.6 | 1,021 | 1,401 | 1,546 | 1,608 | 1,827 |
| Net Debt 1 | 360.1 | 501.5 | 1,213 | 468.9 | -541.2 | -826.6 | -1,743 | -2,547 |
| Reference price 2 | 246.52 | 209.63 | 218.50 | 191.42 | 258.00 | 210.98 | 210.98 | 210.98 |
| Nbr of stocks (in thousands) | 145,640 | 146,405 | 147,062 | 146,884 | 146,365 | 144,240 | - | - |
| Announcement Date | 8/5/21 | 8/11/22 | 8/3/23 | 8/1/24 | 7/31/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.92x | 5.24x | 13.45x | 1.15% | 30.43B | |
| 28.6x | 5.1x | 19.55x | 0.32% | 212B | |
| 32.54x | 5.97x | 18.9x | 0.75% | 137B | |
| 38.77x | 10.04x | 22.2x | -.--% | 125B | |
| 17.36x | 3.69x | 11.98x | -.--% | 69.46B | |
| 34.01x | 6.81x | 21.56x | -.--% | 49.56B | |
| 19.02x | 2.21x | 11.23x | 2.71% | 47.2B | |
| 26.91x | 5.36x | 18.3x | 0.74% | 39.08B | |
| 45.73x | 6.38x | 19.6x | -.--% | 37.05B | |
| 42.65x | 6.76x | 23.9x | -.--% | 30.97B | |
| Average | 30.55x | 5.76x | 18.07x | 0.57% | 77.8B | |
| Weighted average by Cap. | 30.64x | 6.00x | 18.68x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RMD Stock
- Valuation ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
